Unraveling the complexity of therapeutic drug monitoring for monoclonal antibody therapies to individualize dose in oncology Tekijä Etienne Chatelut, Jeroen J. M. A. Hendrikx, Jennifer Martin, Joseph Ciccolini, Dirk Jan A. R. Moes

Hae kokoteksti

Anti-cancer treatment schedule optimization based on tumor dynamics modelling incorporating evolving resistance Tekijä Anyue Yin, Johan G. C. van Hasselt, Henk-Jan Guchelaar, Lena E. Friberg, Dirk Jan A. R. Moes

Hae kokoteksti

A Review of Mathematical Models for Tumor Dynamics and Treatment Resistance Evolution of Solid Tumors Tekijä Anyue Yin, Dirk Jan A.R. Moes, Johan G.C. vanHasselt, Jesse J. Swen, Henk‐Jan Guchelaar

Hae kokoteksti

Publisher Correction: Anti-cancer treatment schedule optimization based on tumor dynamics modelling incorporating evolving resistance Tekijä Anyue Yin, Johan G. C. van Hasselt, Henk-Jan Guchelaar, Lena E. Friberg, Dirk Jan A. R. Moes

Hae kokoteksti

Meltdose Tacrolimus Population Pharmacokinetics and Limited Sampling Strategy Evaluation in Elderly Kidney Transplant Recipients Tekijä Jasper Kamp, Tom C. Zwart, Soufian Meziyerh, Paul J. M. van der Boog, Esther E. Nijgh, Koen van Duin, Aiko P. J. de Vries, Dirk Jan A. R. Moes

Hae kokoteksti

Monitoring of Ex Vivo Cyclosporin a Activity in Healthy Volunteers Using T Cell Function Assays in Relation to Whole Blood and Cellular Pharmacokinetics Tekijä Aliede E. in ’t Veld, Manon A. A. Jansen, Bertine W. Huisman, Mascha Schoonakker, Marieke L. de Kam, Dirk Jan A. R. Moes, Mariëtte I. E. van Poelgeest, Jacobus Burggraaf, Matthijs Moerland

Hae kokoteksti

Physiologically based pharmacokinetic modeling of tacrolimus for food–drug and CYP3A drug–drug–gene interaction predictions Tekijä Helena Leonie Hanae Loer, Denise Feick, Simeon Rüdesheim, Dominik Selzer, Matthias Schwab, Donato Teutonico, Sebastian Frechen, Maaike van derLee, Dirk Jan A. R. Moes, Jesse J. Swen, Thorsten Lehr

Hae kokoteksti

The effect of genetic variants in the transcription factor TSPYL family on the CYP3A4 mediated cyclosporine metabolism in kidney transplant patients Tekijä Qinglian Zhai, Dirk Jan A. R. Moes, Teun vanGelder, Maaike van derLee, Jan‐Stephan Sanders, Frederike J. Bemelman, Johan W. deFijter, Kathrin Klein, Matthias Schwab, Jesse J. Swen

Hae kokoteksti

Immune Monitoring of Mycophenolate Mofetil Activity in Healthy Volunteers Using <i>Ex Vivo</i> T Cell Function Assays Tekijä Aliede E. in ’t Veld, Manon A. A. Jansen, Marieke L. de Kam, Yalҫin Yavuz, Dirk Jan A. R. Moes, Kathalijne A. Oudhoff, Mariette I. E. van Poelgeest, Jacobus Burggraaf, Matthijs Moerland

Hae kokoteksti

Physiologically‐based pharmacokinetic modeling of quinidine to establish a CYP3A4, P‐gp, and CYP2D6 drug–drug–gene interaction network Tekijä Denise Feick, Simeon Rüdesheim, Fatima Zahra Marok, Dominik Selzer, Helena Leonie Hanae Loer, Donato Teutonico, Sebastian Frechen, Maaike van derLee, Dirk Jan A. R. Moes, Jesse J. Swen, Matthias Schwab, Thorsten Lehr

Hae kokoteksti

Immune responsiveness in stable kidney transplantation patients: Complete inhibition of T‐cell proliferation but residual T‐cell activity during maintenance immunosuppressive treat... Tekijä Aliede E. in ’t Veld, Boukje C. Eveleens Maarse, Maria J. Juachon, Soufian Meziyerh, Aiko P. J. deVries, Aline L. vanRijn, Mariet C. W. Feltkamp, Dirk Jan A. R. Moes, Jacobus Burggraaf, Matthijs Moerland

Hae kokoteksti

Quantitative modeling of tumor dynamics and development of drug resistance in non‐small cell lung cancer patients treated with erlotinib Tekijä Anyue Yin, G. D. Marijn Veerman, Johan G. C. vanHasselt, Christi M. J. Steendam, Hendrikus Jan Dubbink, Henk‐Jan Guchelaar, Lena E. Friberg, Anne‐Marie C. Dingemans, Ron H. J. Mathijssen, Dirk Jan A. R. Moes

Hae kokoteksti

A comparison of the effectiveness of different doses of tocilizumab and sarilumab in the treatment of severe COVID-19: a natural experiment due to drug shortages Tekijä Maaike C. Swets, Rob J. Moss, Flip Kor, Doranne Hilarius, Dirk Jan A.R. Moes, Willemijn EM Berkhout, Leon M. van den Toorn, Niels C. Gritters van den Oever, Renee de Valk, Frits R. Rosendaal, Nicole Hunfeld, Geert H. Groeneveld, Mark G.J. de Boer

Hae kokoteksti

Anti-T-lymphocyte globulin exposure is associated with acute graft-versus-host disease and relapse in pediatric acute lymphoblastic leukemia patients undergoing hematopoietic stem... Tekijä Lisa V.E. Oostenbrink, Erik G.J. von Asmuth, Cornelia M. Jol-van der Zijde, Anja M. Jansen-Hoogendijk, Carly Vervat, Robbert G.M. Bredius, Maarten J.D. van Tol, Marco W. Schilham, Petr Sedlacek, Marianne Ifversen, Adriana Balduzzi, Peter Bader, Christina Peters, Dirk Jan A.R. Moes, Arjan C. Lankester

Hae kokoteksti

Voclosporin and the Antiviral Effect Against SARS-CoV-2 in Immunocompromised Kidney Patients Tekijä Eline J. Arends, Soufian Meziyerh, Dirk Jan A.R. Moes, Sylvia W.A. Kamerling, Sandra van der Kooy, Natacha S. Ogando, Eric J. Snijder, Martijn van Hemert, Leo G. Visser, Mariet C.W. Feltkamp, Eric C.J. Claas, Ton J. Rabelink, Cees van Kooten, Aiko P.J. de Vries, Y.K. Onno Teng

Hae kokoteksti

Tacrolimus versus mycophenolate for AutoImmune hepatitis patients with incompLete response On first-line therapy (TAILOR study): a study protocol for a phase III, open-label, multi... Tekijä Anna E. C. Stoelinga, Maarten E. Tushuizen, Wilbert B. van den Hout, Mar D. M. Rodriguez Girondo, Elsemieke S. de Vries, Amar D. Levens, Dirk-Jan A. R. Moes, Tom J. G. Gevers, Suzanne van der Meer, Hans T. Brouwer, Hendrik J. M. de Jonge, Ynte S. de Boer, Ulrich H. W. Beuers, Adriaan J. van der Meer, Aad P. van den Berg, Maureen M. J. Guichelaar, Joost P. H. Drenth, Bart van Hoek, on behalf of the Dutch Autoimmune Hepatitis Group

Hae kokoteksti